| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2958.1994.TB01026.X |
| P698 | PubMed publication ID | 8065258 |
| P50 | author | Anthony Maxwell | Q37380949 |
| P2093 | author name string | E J Gilbert | |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 365-373 | |
| P577 | publication date | 1994-05-01 | |
| P1433 | published in | Molecular Microbiology | Q6895967 |
| P1476 | title | The 24 kDa N-terminal sub-domain of the DNA gyrase B protein binds coumarin drugs | |
| P478 | volume | 12 |
| Q36474350 | ATP-bound conformation of topoisomerase IV: a possible target for quinolones in Streptococcus pneumoniae |
| Q34394101 | Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization. |
| Q44447205 | Agonist-independent desensitization and internalization of the human platelet-activating factor receptor by coumermycin-gyrase B-induced dimerization. |
| Q92883292 | Application of Fragment-Based Drug Discovery against DNA Gyrase B |
| Q44476763 | Characterization of quercetin binding site on DNA gyrase |
| Q72315721 | Characterization of the binding site for cyclothialidine on the B subunit of DNA gyrase |
| Q38306083 | Chimeric VEGFRs are activated by a small-molecule dimerizer and mediate downstream signalling cascades in endothelial cells |
| Q40846816 | Coumermycin-induced dimerization of GyrB-containing fusion proteins. |
| Q40902870 | DNA gyrase as a drug target |
| Q34214929 | Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. |
| Q39781947 | GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin. |
| Q27740876 | Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone |
| Q39781473 | Mode of action of GR122222X, a novel inhibitor of bacterial DNA gyrase. |
| Q33695106 | Modulation of gyrase-mediated DNA cleavage and cell killing by ATP. |
| Q33690598 | Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity |
| Q42235334 | Oligomerization-primed coiled-coil domain interaction with Ubc13 confers processivity to TRAF6 ubiquitin ligase activity |
| Q35311984 | Potentiation of Helicobacter pylori CagA protein virulence through homodimerization |
| Q39718513 | Probing the role of the ATP-operated clamp in the strand-passage reaction of DNA gyrase |
| Q39837651 | Ser-127-to-Leu substitution in the DNA gyrase B subunit of Streptococcus pneumoniae is implicated in novobiocin resistance |
| Q41961468 | Silencing of glycopeptide resistance in Enterococcus faecalis BM4405 by novobiocin |
| Q35067827 | The ectodomain of the Toll-like receptor 4 prevents constitutive receptor activation |
| Q39117573 | The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA). |
| Q41064279 | The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography |
| Q49832269 | Topoisomerases as anticancer targets |
Search more.